Tax & Accounting Services for Boston Tech Startups
Specialized tax planning, R&D credits, and CFO services for venture-backed startups in Boston, Cambridge, and the Greater Boston area, delivered remotely. Navigate Massachusetts's complex tax landscape while maximizing federal and state R&D credits. Serving biotech, AI, SaaS, and fintech innovators.
Why Boston Startups Choose SpryTax
Boston's innovation ecosystem, from MIT and Harvard spin-outs to world-class biotech and AI companies, demands sophisticated tax expertise. Massachusetts has complex tax rules, but also offers a state R&D credit. We help Boston startups navigate this landscape and maximize savings.
Massachusetts R&D Tax Credits
Massachusetts offers a state research credit of 10% of qualified research expenses above a base amount, plus 15% of basic research payments, on top of the federal credit. The MA credit is generally nonrefundable with a 15-year carryforward; refunds are limited to life sciences companies certified by the Massachusetts Life Sciences Center.
- Federal + MA R&D credits (15-year MA carryforward)
- Biotech and life sciences qualification
- AI/ML algorithm development credits
Biotech & Life Sciences Expertise
Boston is one of the world's leading biotech hubs. We understand FDA milestone accounting, clinical trial cost accruals, grant accounting (NIH, SBIR), and the unique R&D credit opportunities for life sciences companies.
- Clinical trial and research accounting
- NIH/SBIR grant accounting
- FDA milestone accounting
Massachusetts Tax Compliance
Massachusetts has an 8% corporate excise tax on income plus a $2.60 per $1,000 property or net worth measure, single sales factor apportionment, and active enforcement. We navigate MA DOR compliance, combined reporting, and multi-state taxation to minimize your tax burden legally.
- MA corporate excise tax optimization
- Apportionment and nexus planning
- Sales tax compliance (6.25%, including SaaS)
VC & University Ecosystem
Boston-area venture investors and university tech transfer offices have high expectations. We deliver institutional-grade financials that support fundraising and licensing deals.
- Monthly GAAP-compliant financials
- IP licensing revenue recognition
- Board-ready reporting packages
Delaware + MA Compliance
Like other startup hubs, most Boston companies incorporate in Delaware. We manage dual-state compliance, ensuring you meet both Delaware franchise tax and Massachusetts corporate excise tax requirements.
- Delaware franchise tax optimization
- MA foreign corporation registration
- Annual compliance calendar management
Stock Options & QSBS Planning
Federal QSBS can exclude up to $10M (stock issued before July 5, 2025) or $15M (stock issued after July 4, 2025) of gain, but Massachusetts doesn't fully follow the federal exclusion. We provide 409A valuations and help your equity structure qualify.
- 409A valuations for option grants
- QSBS planning (federal tax-free exit)
- ISO/NSO grant structuring
Boston Tax Challenges We Solve
Complex MA Tax Apportionment
Starting with tax year 2025, Massachusetts requires all corporations to use single sales factor apportionment, which can be beneficial or detrimental depending on where your customers are located. For SaaS companies, determining "sales sourcing" for MA purposes is particularly complex.
Our Solution:
- • Single-sales factor apportionment optimization
- • Market-based sourcing analysis for services
- • Multi-state nexus and income allocation
- • Quarterly estimated tax planning
Biotech R&D Credit Complexity
Life sciences R&D credits require careful documentation of qualified research activities, clinical trial expenses, and FDA-related costs. Large credit claims draw scrutiny from both the IRS and the Massachusetts DOR.
Our Solution:
- • Clinical trial expense documentation and tracking
- • Four-part test compliance for biotech activities
- • Contemporary documentation best practices
- • MA DOR audit defense and support
University IP & Licensing Issues
Many Boston startups license IP from MIT, Harvard, or other universities. These agreements create complex revenue recognition issues, royalty payment obligations, and tax considerations that require specialized accounting expertise.
Our Solution:
- • IP licensing revenue recognition (ASC 606)
- • Royalty payment accounting and tracking
- • Equity-for-IP transaction structuring
- • R&D collaboration agreement accounting
High Personal Income Tax Impact
Massachusetts adds a 4% surtax on income over about $1.1M ($1,107,750 for 2026), on top of the 5% base rate, for a 9% top rate. This impacts founder compensation, stock option exercises, and exit planning. Strategic timing and structure can significantly reduce personal tax burdens.
Our Solution:
- • Founder compensation tax optimization
- • Stock option exercise timing strategies
- • QSBS planning for federal tax-free gains
- • Exit year tax planning and domicile analysis
Serving Tech Startups Across Greater Boston
From Kendall Square biotech labs to Seaport District SaaS companies and Cambridge AI startups, we work remotely with innovative companies throughout the Boston metropolitan area.
Kendall Square
Back Bay
Seaport District
Cambridge
Financial District
Somerville
Also serving the Greater Boston Metro:
Cambridge
Kendall Sq, MIT, Harvard Innovation Lab
Somerville
Assembly Row, Union Square, Davis Square
Brookline
Coolidge Corner, Longwood Medical
Waltham/128
Route 128 tech corridor, Waltham
How We Help a Kendall Square Biotech with R&D Credits & Tax Planning
The Challenge:
A typical scenario: a biotech startup in Kendall Square (Cambridge) has an accountant who doesn't focus on life sciences R&D credits, hasn't evaluated MA Life Sciences Center certification, and can't properly account for an NIH SBIR award or a university licensing agreement. It needs better financials to support Series A fundraising.
Our Solution:
- Biotech R&D credit study for federal and MA credits
- Accounting for the NIH SBIR award and allowable costs
- IP licensing accounting for university royalty payments
- Clinical trial cost tracking and accruals
- Created investor-ready monthly financials and KPI dashboard
Results:
Illustrative scenario based on common Boston biotech situations, not a specific client. Actual results depend on each company's facts.
Our Services for Boston Startups
Tax Planning & Filing
- • Federal and MA corporate excise tax returns
- • Multi-state tax compliance and apportionment
- • Sales tax registration and filing (MA 6.25%, incl. SaaS)
- • Quarterly estimated tax calculations
- • QSBS and exit tax planning strategies
R&D Tax Credits
- • Federal R&D credit (20% of QREs above a base, or 14% ASC)
- • MA R&D credit (10% above base; refundable only if MLSC-certified)
- • Biotech and life sciences R&D qualification
- • AI/ML algorithm development credits
- • Retroactive claims and audit defense
Biotech & Life Sciences Accounting
- • Monthly GAAP-compliant financial statements
- • Clinical trial cost tracking and accruals
- • NIH/SBIR grant accounting
- • FDA milestone accounting
- • IP licensing revenue recognition (ASC 606)
CFO Services
- • Fundraising financial modeling and projections
- • Board presentation deck preparation
- • Strategic tax planning for M&A and exits
- • Cap table management and dilution analysis
- • Due diligence coordination and support
Equity & 409A Valuations
- • IRS-compliant 409A valuations for stock options
- • ISO and NSO grant structuring and planning
- • QSBS qualification planning for tax-free exits
- • 83(b) election preparation and filing
- • ASC 718 equity compensation accounting
Massachusetts Payroll
- • MA payroll tax compliance and withholding
- • Multi-state payroll setup (all 50 states)
- • Remote employee tax compliance
- • Paid Family Medical Leave (PFML) compliance
- • W-2, 1099, and annual reporting
Ready to maximize your Boston startup's R&D credits?
Work with a remote team that knows federal and MA R&D credits and Massachusetts startup tax planning. Get a free consultation to discover your savings potential.
Frequently Asked Questions
How does Massachusetts's R&D tax credit work?
Massachusetts offers a research credit equal to 10% of qualified research expenses above a base amount (an alternative simplified method is also available), plus 15% of basic research payments to universities and similar organizations. The credit is generally nonrefundable, but unused credits carry forward for 15 years. Life sciences companies certified by the Massachusetts Life Sciences Center may be able to receive a refund of 90% of unused credits. It's claimed alongside the federal credit, and biotech, software, and AI development can all qualify.
What is Massachusetts's corporate excise tax?
Massachusetts charges an 8% excise on income apportioned to MA, plus $2.60 per $1,000 of taxable tangible property or net worth, with a $456 minimum. Since tax year 2025, all corporations use single sales factor apportionment, so your tax depends on where your customers are located. Calendar-year Form 355 returns are due the 15th day of the 4th month (April 15). We help optimize apportionment and minimize MA tax liability through strategic planning.
Do biotech companies get special R&D credit treatment?
Biotech and life sciences companies can claim R&D credits on qualified research activities including clinical trials, FDA compliance work, and drug development. However, documentation requirements are stricter. You must show the research meets the "four-part test" (technical uncertainty, experimentation, technological in nature, qualified purpose). We specialize in biotech R&D credit documentation and audit defense.
How do I handle NIH grants and SBIR funding from an accounting perspective?
NIH grants and SBIR awards are generally recognized as qualifying costs are incurred or milestones are met, depending on the award terms and the accounting policy you adopt. Proper accounting requires tracking allowable costs, indirect cost rates, and milestone completion. We have extensive experience with government grant accounting and can ensure compliance with federal requirements.
Does Massachusetts recognize QSBS for tax-free exits?
Not fully. Federal QSBS can exclude up to $10M (stock issued before July 5, 2025) or $15M (stock issued after July 4, 2025) of gain, but Massachusetts generally taxes long-term gains at 5%, plus the 4% surtax on income over the threshold, with only a limited reduced rate for certain Massachusetts small business stock. Avoiding federal tax of up to 23.8% (20% plus the 3.8% net investment income tax) is still significant. We help structure your equity from day one to qualify for QSBS and coordinate timing strategies to minimize MA personal income tax on exits.
Latest on business tax basics & compliance
- Tax ComplianceStartup Tax Deductions Every New Business Owner Should Know in 2026September 27, 2026 · 6 min read
- Tax ComplianceCalifornia Corporate Tax Rate 2026: What Startups Actually PaySeptember 6, 2026 · 7 min read
- Location GuidesBookkeeping for Startups in Illinois: Requirements, Taxes, and Provider OptionsAugust 30, 2026 · 6 min read
- Tax ComplianceTexas Franchise Tax Forms 05-158 and 05-164: A 2026 Guide for StartupsAugust 16, 2026 · 7 min read
- Location GuidesNew York Startup Tax Incentives: Credits, Exemptions, and Programs for 2026August 9, 2026 · 6 min read
- Tax ComplianceNYC Unincorporated Business Tax (UBT): What Startup Founders Need to KnowJuly 5, 2026 · 7 min read